MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$3,672K
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
0
25
80*
-
Research and development
1,345
1,297
1,315*
1,203
Impairment of intangible assets
-
-
0*
0
General and administrative
1,326
1,416
1,393*
1,315
Total operating expenses
2,671
2,713
2,708*
2,518
Loss from operations
-2,671
-2,688
-2,628*
-2,518
Interest income
217
163
165*
187
Interest expense
719
229
82*
57
Foreign exchange losss (gaines)
-104
4
-997*
-418
Change in fair value of derivative and warrant liabilities
128
0
-1*
0
Total other income (expense), net
-734
-62
-913*
-288
Loss before income tax expense (benefit)
-
-
-3,542*
-2,806
Income tax expense (benefit)
-
-
0*
0
Net loss
-3,405
-2,800
-3,542*
-2,806
Gain on extinguishment of series a convertible preferred stock-Series AConvertible Preferred Stock
-
-
-
0
Deemed dividends on preferred stock-Series APreferred Stock
-
-
0*
0
Deemed dividends on preferred stock-Redeemable Series AConvertible Preferred Stock
-
-
0*
-
Deemed dividend on preferred stock-Series AConvertible Preferred Stock
-
-
-
0
Gain on extinguishment of series a preferred stock-Series APreferred Stock
-
-
0*
-
Change in cumulative translation adjustment
-267
-100
-
-
Net loss attributable to common stockholders
-
-
-3,542
-2,806
Total comprehensive loss
-3,672
-2,808
-
-
Basic EPS
-0.21
-0.17
-0.276
-0.19
Basic Average Shares
15,910,724
15,968,591
12,853,705
14,739,800
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
loss
-$3,672K
Net loss
-$3,405K
(-46.77%↓ Y/Y)
Change in cumulative
translation adjustment
-$267K
Loss from operations
-$2,671K
(35.37%↑ Y/Y)
Total other income
(expense), net
-$734K
(-140.49%↓ Y/Y)
Interest income
$217K
(-8.44%↓ Y/Y)
Total operating
expenses
$2,671K
(-35.37%↓ Y/Y)
Interest expense
$719K
(5891.67%↑ Y/Y)
Change in fair value of
derivative and warrant...
$128K
Foreign exchange losss
(gaines)
-$104K
(-106.55%↓ Y/Y)
Research and development
$1,345K
(-42.05%↓ Y/Y)
General and
administrative
$1,326K
(-26.82%↓ Y/Y)
Buy us a coffee
Allarity Therapeutics, Inc. (ALLR)
Allarity Therapeutics, Inc. (ALLR)